EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Glycosylated RNAs: discovery and implications in cancer biology

Shuai Tang, Ximo Wang, Fangmin Chen, Benyi Li

Frontiers in Oncology · 04.02.2026 · 16

DOI: 10.3389/fonc.2026.1719799 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 04.02.2026. Verfasst von Shuai Tang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Tianjin Third Central Hospital, Tianjin, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glycosylated RNAs (glycoRNAs) are a newly discovered class of biomolecules that challenge the long-standing paradigm that glycosylation occurs exclusively on proteins and lipids. Early studies indicate that glycoRNAs are broadly distributed across cell types and can be detected at the cell surface as well as in other cellular compartments. Emerging evidence suggests that glycoRNAs may participate in processes such as intercellular communication and immune regulation, but their context-dependent functions in physiology and disease, including cancer, are only beginning to be elucidated. Recent advances in detection techniques have enabled more comprehensive profiling of glycoRNAs and their associated cell-surface RNA-binding proteins, providing initial links between glycoRNA patterns, tumor aggressiveness, immune checkpoint regulation and extracellular vesicle–mediated signaling. However, many of these connections remain correlative or are inferred by analogy to protein and lipid glycosylation. In this review, we summarize current knowledge of glycoRNA biosynthesis, cell-surface display and detection methods, with a particular focus on emerging observations in cancer-related contexts. We also discuss the potential of glycoRNAs as biomarkers and therapeutic targets, while highlighting key unanswered questions regarding their biosynthetic pathways, structural diversity and mechanistic roles. Addressing these challenges with integrated omics and spatial approaches will be essential for defining glycoRNA biology and evaluating their feasibility as tools for precision oncology.

Schlagwörter

Stichwörter der Autor:innen

cancercell surface biomarkerextracellular vesiclesglycoRNAstumor microenvironment

Autor:innen und Institutionen

  • Department of Urology, Tianjin Third Central Hospital, Tianjin, China.
  • Department of Urology, The University of Kansas Medical Center, Kansas, KS, United States.
  • College of Medicine, Nankai University, Tianjin, China.
  • Department of Urology, Wuhan Sixth Hospital, Wuhan, China.

Zitieren

APA

Tang, S., Wang, X., Chen, F., & Li, B. (2026). Glycosylated RNAs: discovery and implications in cancer biology. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1719799

Vancouver

Tang S, Wang X, Chen F, Li B. Glycosylated RNAs: discovery and implications in cancer biology. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1719799

BibTeX
@article{Tang2026,
  author = {Tang, Shuai and Wang, Ximo and Chen, Fangmin and Li, Benyi},
  title = {Glycosylated RNAs: discovery and implications in cancer biology},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1719799}
}
Kostenlos starten →